Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
06/2012
06/21/2012WO2012082593A2 Electroactive material and devices made with such materials
06/21/2012WO2012081665A1 Substance capable of inhibiting glycine transporter
06/21/2012WO2012081640A1 Azo compound, ink composition, recording method and colored material
06/21/2012WO2012081031A1 Process for preparing tetrabenazine
06/21/2012WO2012080728A1 Imidazo [4, 5 -c] quinolin- 1 -yl derivative useful in therapy
06/21/2012WO2012080457A1 Bicyclic ring system substituted sulfonamide functionalised phenols as medicaments
06/21/2012WO2012080456A1 Bicyclic ring system substituted amide functionalised phenols as medicaments
06/21/2012WO2012080451A1 Imidazopyridines as respiratory syncytial virus antiviral agents
06/21/2012WO2012080450A1 Azaindoles as respiratory syncytial virus antiviral agents
06/21/2012WO2012080449A1 Azabenzimidazoles as respiratory syncytial virus antiviral agents
06/21/2012WO2012080447A1 Indoles as respiratory syncytial virus antiviral agents
06/21/2012WO2012080446A1 Benzimidazole respiratory syncytial virus inhibitors
06/21/2012WO2012080324A1 Dyeing composition comprising a fatty substance, a pyrazolopyridine oxidation base and a coupler
06/21/2012WO2012080221A1 New compounds for the treatment of neurodegenerative diseases
06/21/2012WO2012080220A1 Novel compounds for the treatment of neurodegenerative diseases
06/21/2012WO2012079532A1 Dicoumarol-like compounds and preparation method and use thereof
06/21/2012WO2012051213A3 Therapeutic 5,6,5-tricyclic analogs
06/21/2012WO2011145035A8 Novel 3,5-disubstitued-3h-imidazo[4,5-b]pyridine and 3,5- disubstitued -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of protein kinases
06/21/2012US20120157481 Tricyclic pyrimidine derivatives as wnt antagonists
06/21/2012US20120157471 Benzimidazole derivatives
06/21/2012US20120157470 Salts and crystalline forms of an apoptosis-inducing agent
06/21/2012US20120157469 Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof
06/21/2012US20120157466 Heterocyclic compounds with cxcr3 antagonist activity
06/21/2012US20120157464 Use of azabicycloalkyl derivatives or pyrrolidine-2-one derivatives for the treatment or prevention of ataxia
06/21/2012US20120157460 Tetrahydro-azacarboline mch-1 antagonists, methods of making, and uses thereof
06/21/2012US20120157452 1h-pyrazolo[3,4-b] pyridine compounds for inhibiting raf kinase
06/21/2012US20120157442 Heteroaryl btk inhibitors
06/21/2012US20120157440 Novel fused pyridine compounds as casein kinase inhibitors
06/21/2012US20120157306 Substituted Fused Pyrimidinones and Dihydropyrimidinones
06/21/2012US20120156491 SERS Reporter Molecules and Methods
06/21/2012US20120156219 Nitrogen-containing heterocyclic compounds and medicinal use thereof
06/21/2012US20120153270 Heterocyclic compound and organic light-emitting device using the same
06/21/2012US20120153269 Heterocyclic compound and organic light-emitting device using the same
06/21/2012CA2822062A1 Inhibitors of influenza viruses replication
06/21/2012CA2822059A1 Inhibitors of influenza viruses replication
06/21/2012CA2822057A1 Inhibitors of influenza viruses replication
06/21/2012CA2822003A1 Imidazopyridines as respiratory syncytial virus antiviral agents
06/21/2012CA2822002A1 Azaindoles as respiratory syncytial virus antiviral agents
06/21/2012CA2822001A1 Azabenzimidazoles as respiratory syncytial virus antiviral agents
06/21/2012CA2822000A1 Indoles as respiratory syncytial virus antiviral agents
06/21/2012CA2821999A1 Benzimidazole respiratory syncytial virus inhibitors
06/21/2012CA2821712A1 Substituted n-(1h-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type iii receptor tyrosine kinase inhibitors
06/21/2012CA2819214A1 Azo compound, ink composition, recording method and colored material
06/21/2012CA2819171A1 New compounds for the treatment of neurodegenerative diseases
06/20/2012EP2465858A1 Process for preparing a pyrido[1,2-a]pyrrolo[1',2':3,4]imidazo[1,2-d]pyrazine-8-carboxamide derivative
06/20/2012EP2464647A1 Azaindazoles as btk kinase modulators and use thereof
06/20/2012EP2464646A1 Process for the preparation of cathepsin s inhibitors
06/20/2012EP2464645A1 Fused heterocyclic compounds as ion channel modulators
06/20/2012EP2464628A1 Bi - or tricyclic sterically hindered alkoxyamines and process for their preparation
06/20/2012EP2464232A1 Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
06/20/2012EP2300473B1 Fumarate salt of 4-bromophenyl 1,4-diazabicyclo[3.2.2]nonane-4-carboxylate, crystalline forms thereof, preparation thereof and therapeutic use thereof
06/20/2012EP2203442B1 Substituted pyrrolo-pyrimidine derivatives, process for their preparation and their use as kinase inhibitors
06/20/2012EP2152707B1 [6,5]-bicyclic gpr119 g protein-coupled receptor agonists
06/20/2012EP1963276B1 N-linked aryl heteroaryl inhibitors of lta4h for treating inflammation
06/20/2012EP1694672B1 Novel chelating agents and highly luminescent and stable chelates and their use
06/20/2012CN102503959A Tricyclic compounds and preparation method thereof, and medicinal composition containing compounds and application thereof
06/20/2012CN102503942A Fluoroquinolone derivative and preparation and medicinal application thereof
06/20/2012CN102503941A Triazol quinoline derivative used as positive inotropic medicament
06/20/2012CN101787025B Substituted-evodiamine anti-tumor and antifungal compounds and preparation method thereof
06/20/2012CN101547922B Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists
06/20/2012CN101516880B Process for the preparation of pyrido[2,1-a]isoquinoline derivatives comprising optical resolution of an enamine
06/20/2012CN101312972B Bicyclic cinnamide compound
06/19/2012USRE43481 Diazepan derivatives or salts thereof
06/19/2012US8202994 Pentarylene- and hexarylenetetracarboximides and preparation thereof
06/19/2012US8202881 JAK2 inhibitors and their use for the treatment of myeloproliferative diseases and cancer
06/19/2012CA2685219C Diazaquinolones that inhibit prolyl hydroxylase activity
06/19/2012CA2683939C Aspartate of 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza-spiro[3.4]oct-6-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid, method for preparing the same, and antimicrobial pharmaceutical composition comprising the same
06/19/2012CA2607151C Hiv integrase inhibitors
06/19/2012CA2522784C Antiandrogens with marginal agonist activity and methods of use
06/14/2012WO2012078994A1 Imidazo [1, 2-a] pyridine sulfonamides as trpm8 modulators
06/14/2012WO2012078802A1 PREPARATION OF SUBSTITUTED-4,5-DIHYDROPYRROLO[4,3,2-de][2,6]NAPHTHYRIDIN-3(1H)-ONES
06/14/2012WO2012078777A1 Bicyclic compounds as pim inhibitors
06/14/2012WO2012077765A1 Polynuclear platinum complex catalyst and method of artificial photosynthesis using same
06/14/2012WO2012077431A1 Process for manufacture of organic electroluminescent element
06/14/2012WO2012077031A1 Substituted imidazoquinoline derivatives
06/14/2012WO2012076941A1 Pyrrolo[2,1-c][1,4]benzodiazepine linked imidazo[1,5-a]pyridine conjugates as potential antitumour agents and process for the preparation thereof
06/14/2012WO2012076674A1 Imidazo(4,5-b)pyridine-6-carboxamides as anti-inflammatory agents
06/14/2012WO2012076430A1 Triazolopyridine compounds
06/14/2012WO2012075678A1 Substituted thiazolyl pyrazolo pyridine compound and medicinal use thereof
06/14/2012WO2011072241A9 4-oxo-1h-quinoline-3-carboxamides as modulators of atp-binding cassette transporters
06/14/2012US20120149897 Method of preparing nitrogen-doped graphene and nitrogen-doped graphene prepared thereby
06/14/2012US20120149709 Pyrazinoisoquinoline compounds
06/14/2012US20120149702 Inhibitors of cellular necrosis
06/14/2012US20120149699 IMIDAZO[1,2-a]PYRIDINE SULFONAMIDES AS TRPM8 MODULATORS
06/14/2012US20120149698 Nouvel compounds
06/14/2012US20120149688 Platelet adp receptor inhibitors
06/14/2012US20120149686 Kinase inhibitors and method of treating cancer with same
06/14/2012US20120149684 Akt inhibitors
06/14/2012US20120149681 Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
06/14/2012US20120149680 Kinase inhibitors
06/14/2012CA2820075A1 Imidazo [1, 2-a] pyridine sulfonamides as trpm8 modulators
06/14/2012CA2819955A1 Substituted imidazoquinoline derivatives
06/14/2012CA2819373A1 Bicyclic compounds as pim inhibitors
06/14/2012CA2816829A1 Triazolopyridine compounds
06/13/2012EP2463288A1 Compound having substituted pyridyl group and pyridoindole ring structure linked through phenylene group, and organic electroluminescent device
06/13/2012EP2463287A1 Compound having substituted anthracene ring structure and pyridoindole ring structure and organic electroluminescence device
06/13/2012EP2462142A1 Metabotropic glutamate receptor modulators
06/13/2012EP2462141A1 Novel azaheterocyclic compounds
06/13/2012EP2462116A2 Process for the manufacture of pharmaceutically active compounds
06/13/2012EP2461869A1 Novel bicyclic urea compounds
1 ... 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 ... 646